Centiva Capital’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04M Sell
293,500
-72,200
-20% -$296K 0.01% 573
2025
Q4
$1.73M Sell
365,700
-595,000
-62% -$2.65M 0.01% 463
2025
Q3
$4.6M Buy
960,700
+652,700
+212% +$2.57M 0.04% 244
2025
Q2
$742K Buy
308,000
+108,000
+54% +$266K 0.01% 763
2025
Q1
$522K Sell
200,000
-950,000
-83% -$3.06M 0.02% 784
2024
Q4
$4.38M Buy
1,150,000
+500,000
+77% +$2.7M 0.09% 112
2024
Q3
$4.66M Buy
650,000
+645,000
+12,900% +$4.58M 0.09% 187
2024
Q2
$36.6K Sell
5,000
-816,100
-99% -$7.12M ﹤0.01% 1944
2024
Q1
$8.22M Buy
821,100
+612,700
+294% +$5.36M 0.2% 73
2023
Q4
$1.46M Sell
208,400
-291,600
-58% -$1.94M 0.03% 456
2023
Q3
$3.97M Sell
500,000
-108,500
-18% -$684K 0.09% 215
2023
Q2
$3.37M Buy
+608,500
New +$3.34M 0.07% 264

Other funds holding MSOS

Centiva Capital's MSOS Position: Q4 2025 in Review

Centiva Capital sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q4 2025, closing a stake of 350,000 shares — an estimated $1.56M sold.

Centiva Capital first reported a position in MSOS in Q2 2023 and held it in 10 quarters. The position peaked at $1.79M in Q3 2024. 183 funds tracked by Wall St. Rank hold MSOS as of Q4 2025.

  • Centiva Capital reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q4 2025 after selling out during the quarter.
  • Centiva Capital sold 350,000 AdvisorShares Pure US Cannabis ETF shares in Q4 2025, an estimated $1.56M.
  • Centiva Capital first reported a position in AdvisorShares Pure US Cannabis ETF in Q2 2023 and held it in 10 quarters.
  • Centiva Capital's AdvisorShares Pure US Cannabis ETF position peaked at $1.79M in Q3 2024.
  • 183 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q4 2025.

Based on Centiva Capital's 13F filing for Q4 2025, filed 13 Feb 2026.